Co-Founder
CurrentBrainfulness is an innovative startup in the field of Neurobiology that has developed a new device and software based on the idea of "Repetitive Triggered Somatosensory Discrimination" with the goal of treating depression and anxiety without any side effects. We have received approval from the Helsinki Committee and the Ministry of Health to use the device on humans, as well as a grant from the Israeli Chief Scientist. Brainfulness has 4 approved patents in Germany, Japan, US, and Israel, and has conducted a successful open-pilot clinical study with positive results in 2015.